Patients with phenylketonuria develop almost normally if diagnosed neonatally and treated by diet; however, executive dysfunction remains. This Review discusses the disorder's diagnosis, the outcome of traditional treatment by dietary restriction and outlines new treatment possibilities, including tetrahydrobiopterin and other chaperone proteins, enzymatic treatment, large neutral amino acid supplementation and possibly gene therapy.
